COVID-19 Fact Check

Glenmark launches India's first COVID-19 nasal spray - FabiSpray. The treatment claims to check the virus in the nose itself. It has been approved for Indian markets.

Dr Vikram Saini, Associate Professor, Laboratory of Infection Biology and Translational Research, Department of Biotechnology, AIIMS in New Delhi, and his team have developed a new Viral Transport Medium kit for COVID-19 testing.

Click here to see if you can get the COVID booster shot, which has been approved for certain groups across India. Check your eligibility and things to know here.

Dr Sushila Kataria from Medanta, Gurugram, explains how the Delta and Omicron variants of the Coronavirus differ, and how identifying the right strain early can benefit the treatment protocol.

Covaxin vaccines is being administered by India to children between 15 to 18 years of age. Dr Vikas Maurya, pulmonologist at Fortis Hospital, answers questions about the expiry of vaccines.

In Phase 3 of its clinical trial, Merck & Co's anti-COVID Molnupiravir may reach Indian markets soon. Here's what you need to know about its cost, side-effects and treatment.

Dr Vikas Maurya, Dr Mala Kaneria and Dr Sunil Jain help us understand whether we need to take the booster shot against COVID-19 for better immunity against the virus.

Dr Mrinal Sircar Pulmonologist Fortis, Noida, helps us understand what the Delta Plus variant is and the efficacy of vaccines.

Dr Mala Kaneria, director, Department of Infectious Diseases at Jaslok Hospital and Research Centre, sheds light on whether anaesthesia can pose a danger to health or even the risk of death after vaccination.

Dr Charu Arora, a cardiologist and yoga teacher helps explain what techniques you can practise at home to feel better when recovering from COVID-19.